Oct 31 (Reuters) - ALX Oncology Holdings Inc ALXO.O :
* ALX ONCOLOGY ENTERS $100 MILLION LOAN FACILITY AGREEMENT
WITH
OXFORD FINANCE AND SILICON VALLEY BANK TO SUPPORT ONGOING
DEVELOPMENT OF EVORPACEPT
* ALX ONCOLOGY HOLDINGS - WITH ABILITY TO DRAW DOWN UP TO
$50
MILLION OF FACILITY AT CO DISCRETION, EXPECT TO BE ABLE TO
EXTEND CASH RUNWAY TO MID-2025
* ALX ONCOLOGY HOLDINGS INC - FACILITY WILL SUPPORT
CONTINUED
DEVELOPMENT OF EVORPACEPT, A NEXT GENERATION CD47 BLOCKING
THERAPEUTIC
Source text for Eikon: ID:nGNX13kGdh
Further company coverage: ALXO.O
((Reuters.Briefs@thomsonreuters.com;))